BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38000682)

  • 1. Prognostic value of mitotic count in leiomyosarcoma: A comprehensive monocentric retrospective study.
    Grimaudo MS; Renne SL; Colombo P; Giordano L; Gennaro N; Laffi A; Cariboni U; Cananzi FCM; Ruspi L; Santoro A; Bertuzzi AF
    Hum Pathol; 2024 Jan; 143():17-23. PubMed ID: 38000682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine leiomyosarcoma: an updated series.
    Rauh-Hain JA; Oduyebo T; Diver EJ; Guseh SH; George S; Muto MG; del Carmen MG
    Int J Gynecol Cancer; 2013 Jul; 23(6):1036-43. PubMed ID: 23714705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery.
    Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Saada-Bouzid E; Bertucci F; Bompas E; Alexandre J; Collard O; Lebrun-Ly V; Soulier P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
    ESMO Open; 2021 Aug; 6(4):100209. PubMed ID: 34325109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
    Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
    Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases.
    Wang WL; Soslow R; Hensley M; Asad H; Zannoni GF; de Nictolis M; Branton P; Muzikansky A; Oliva E
    Am J Surg Pathol; 2011 Apr; 35(4):522-9. PubMed ID: 21383611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
    Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
    Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
    Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.
    Li Q; Zhuang R; Zhu J; Lu W; Hou Y; Liu J; Zhang Y; Wang Y; Liu T; Wang Z; Zhou Y
    Future Oncol; 2015; 11(12):1759-66. PubMed ID: 26075444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
    Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
    Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases.
    Paik ES; Kang JH; Kim J; Lee YJ; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Obstet Gynecol Sci; 2019 Mar; 62(2):103-111. PubMed ID: 30918878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
    Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
    Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
    Colombo C; Miceli R; Collini P; Radaelli S; Palassini E; Stacchiotti S; Fiore M; Mariani L; Casali PG; Gronchi A
    Cancer; 2012 Nov; 118(21):5349-57. PubMed ID: 22517186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
    Chou FF; Eng HL; Sheen-Chen SM
    Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in early-stage leiomyosarcoma of the uterus.
    Pelmus M; Penault-Llorca F; Guillou L; Collin F; Bertrand G; Trassard M; Leroux A; Floquet A; Stoeckle E; Thomas L; MacGrogan G
    Int J Gynecol Cancer; 2009 Apr; 19(3):385-90. PubMed ID: 19407564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine leiomyosarcoma: 14-year two-center experience of 31 cases.
    Kim WY; Chang SJ; Chang KH; Yoon JH; Kim JH; Kim BG; Bae DS; Ryu HS
    Cancer Res Treat; 2009 Mar; 41(1):24-8. PubMed ID: 19688068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of CD133 in primary retroperitoneal leiomyosarcoma and its relationship with Ki-67].
    She Y; Liang J; Qiu Y; Liu N; Huang X; Zhao X; Li P
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1241-4. PubMed ID: 24924889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosticators and the role of lymphadenectomy in uterine leiomyosarcomas.
    Ayhan A; Aksan G; Gultekin M; Esin S; Himmetoglu C; Dursun P; Usubutun A; Yuce K
    Arch Gynecol Obstet; 2009 Jul; 280(1):79-85. PubMed ID: 19096861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
    Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
    Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.